Related references
Note: Only part of the references are listed.RNAi prodrugs decrease elevated mRNA levels of Polo-like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients
Iryna Kolosenko et al.
FASEB JOURNAL (2021)
Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients
Oksana Goroshchuk et al.
SCIENTIFIC REPORTS (2020)
DEqMS: A Method for Accurate Variance Estimation in Differential Protein Expression Analysis
Yafeng Zhu et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Small-molecule inhibitors for targeting polo-like kinase 1
Iryna Kolosenko et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
Takumi Kobayashi et al.
BLOOD (2020)
Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors
Sindhu Carmen Sivakumaren et al.
CELL CHEMICAL BIOLOGY (2020)
Identification of a Small Compound Targeting PKM2-Regulated Signaling Using 2D Gel Electrophoresis-Based Proteome-wide CETSA
Ikuko Nagasawa et al.
CELL CHEMICAL BIOLOGY (2020)
Polo-like kinases and acute leukemia
Oksana Goroshchuk et al.
ONCOGENE (2019)
Functional analysis of the biochemical activity of mammalian phosphatidylinositol 5 phosphate 4-kinase enzymes
Swarna Mathre et al.
BIOSCIENCE REPORTS (2019)
PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma
Yong Jae Shin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia
Keli Lima et al.
CANCER GENETICS (2019)
Phosphatidylinositol 5 Phosphate 4-Kinase Regulates Plasma-Membrane PIP3 Turnover and Insulin Signaling
Sanjeev Sharma et al.
CELL REPORTS (2019)
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins
Dorothee Childs et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Targeting the 15-keto-PGE2-PTGR2 axis modulates systemic inflammation and survival in experimental sepsis
Ing-Jung Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients
Iryna Kolosenko et al.
JOURNAL OF CONTROLLED RELEASE (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Vascular Endothelial Growth Factor and Ischemic Heart Disease Risk: A Mendelian Randomization Study
Shiu Lun Au Yeung et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Deletion of the gene Pip4k2c, a novel phosphatidylinositol kinase, results in hyperactivation of the immune system
Hyeseok Shim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
PIP4K and the role of nuclear phosphoinositides in tumour suppression
Roberta Fiume et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Differential profile of PIP4K2A expression in hematological malignancies
Keli Lima et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Multi-omic data analysis using Galaxy
Jorrit Boekel et al.
NATURE BIOTECHNOLOGY (2015)
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
Friedrich B. M. Reinhard et al.
NATURE METHODS (2015)
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry
Holger Franken et al.
NATURE PROTOCOLS (2015)
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
Xiaoqi Liu
TRANSLATIONAL ONCOLOGY (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Mapping Novel Immunogenic Epitopes in IgA Nephropathy
Sang Hoon Woo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib
Michael G. Rolf et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Impairments that Influence Physical Function among Survivors of Childhood Cancer
Carmen L. Wilson et al.
CHILDREN-BASEL (2015)
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
Hartmut Doehner et al.
BLOOD (2014)
Fast and Accurate Database Searches with MS-GF plus Percolator
Viktor Granholm et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAFV600E Mutant Melanoma Cells
Brian D. Cholewa et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Ultrasensitive proteome analysis using paramagnetic bead technology
Christopher S. Hughes et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
HiRIEF LC-MSMS enables deep proteome coverage and unbiased proteogenomics
Rui M. M. Branca et al.
NATURE METHODS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
MS-GF plus makes progress towards a universal database search tool for proteomics
Sangtae Kim et al.
NATURE COMMUNICATIONS (2014)
Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors
Brooke M. Emerling et al.
CELL (2013)
The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation
Rossana Maffei et al.
HAEMATOLOGICA (2013)
Prostaglandin reductase-3 negatively modulates adipogenesis through regulation of PPARγ activity
Yu-Hsiang Yu et al.
JOURNAL OF LIPID RESEARCH (2013)
The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic Leukaemia
Alessia Casolaro et al.
PLOS ONE (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies
Barbara Valsasina et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions
Leonidas Benetatos et al.
ANNALS OF HEMATOLOGY (2011)
NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor
Italo Beria et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
From Plk1 to Plk5 Functional evolution of Polo-like kinases
Guillermo de Carcer et al.
CELL CYCLE (2011)
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Monika Raab et al.
NATURE COMMUNICATIONS (2011)
BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
Dorothea Rudolph et al.
CLINICAL CANCER RESEARCH (2009)
Plk1 and Aurora A regulate the depolymerase activity and the cellular localization of Kif2a
Chang-Young Jang et al.
JOURNAL OF CELL SCIENCE (2009)
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia
A. Farfsing et al.
LEUKEMIA (2009)
A quantitative model of thermal stabilization and destabilization of proteins by ligands
Piotras Cimmperman et al.
BIOPHYSICAL JOURNAL (2008)
OpenMS-An open-source software framework for mass spectrometry
Marc Sturm et al.
BMC BIOINFORMATICS (2008)
Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry
Akiko Seki et al.
SCIENCE (2008)
Structural Basis for Catalytic and Inhibitory Mechanisms of Human Prostaglandin Reductase PTGR2
Yu-Hauh Wu et al.
STRUCTURE (2008)
Selectivity-determining residues in Plk1
Michael Kothe et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo
Martin Steegmaier et al.
CURRENT BIOLOGY (2007)
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
N Syed et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
